{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:34:32Z","timestamp":1762032872715},"reference-count":25,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.vaccine.2010.02.017","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T10:46:25Z","timestamp":1267094785000},"page":"3602-3608","source":"Crossref","is-referenced-by-count":36,"title":["In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7\u00d71010 colony-forming units"],"prefix":"10.1016","volume":"28","author":[{"given":"C.E.","family":"Lyon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.S.","family":"Sadigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Carmolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Harro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Lindow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Ventrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"DeNearing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fingar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Dill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.I.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.","family":"Beardsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Upton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Budhram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.D.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2010.02.017_bib1","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Org"},{"issue":"45","key":"10.1016\/j.vaccine.2010.02.017_bib2","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"issue":"7125","key":"10.1016\/j.vaccine.2010.02.017_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.316.7125.110","article-title":"Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity","volume":"316","author":"Engels","year":"1998","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.017_bib4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/516128","article-title":"Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment","volume":"25","author":"Wain","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2010.02.017_bib5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMp078144","article-title":"Putting typhoid vaccination on the global health agenda","volume":"357","author":"DeRoeck","year":"2007","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2010.02.017_bib6","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.017_bib7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","article-title":"phoP\/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers","volume":"173","author":"Hohmann","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.017_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/421469","article-title":"Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide","volume":"190","author":"Tacket","year":"2004","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2010.02.017_bib9","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.vaccine.2006.10.040","article-title":"Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909","volume":"25","author":"Wahid","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.017_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.017_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/431605","article-title":"The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations","volume":"192","author":"Kirkpatrick","year":"2005","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.017_bib12","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.017_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.017_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2249.2004.02453.x","article-title":"Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system","volume":"136","author":"Cedzynski","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2010.02.017_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0264-410X(02)00410-3","article-title":"Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors","volume":"21","author":"Khan","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.017_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(90)90088-4","article-title":"Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine","volume":"8","author":"Kantele","year":"1990","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.017_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/153.6.1126","article-title":"Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi","volume":"153","author":"Kantele","year":"1986","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.017_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/CDLI.4.3.375-379.1997","article-title":"Standardization of measurement of immunoglobulin-secreting cells in human peripheral circulation","volume":"4","author":"Baqar","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.017_bib19","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1128\/IAI.73.6.3521-3530.2005","article-title":"Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires","volume":"73","author":"Salerno-Goncalves","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.017_bib20","series-title":"Vaccines","first-page":"888","article-title":"Typhoid fever vaccines","author":"Levine","year":"2008"},{"key":"10.1016\/j.vaccine.2010.02.017_bib21","first-page":"9","article-title":"Immunogenicity of Ty21a attenuated \u201cSalmonella typhi\u201d given with sodium bicarbonate or in enteric-coated capsules","volume":"53","author":"Black","year":"1983","journal-title":"Dev Biol Stand"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2010.02.017_bib22","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/clinids\/11.Supplement_3.S552","article-title":"Progress in vaccines against typhoid fever","volume":"11","author":"Levine","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.017_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/154.2.342","article-title":"Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines","volume":"154","author":"Tacket","year":"1986","journal-title":"J Infect Dis"},{"issue":"9702","key":"10.1016\/j.vaccine.2010.02.017_bib24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.017_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T16:44:44Z","timestamp":1590684284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":25,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0264410X10001854"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}